Table 1.
Performance of individual rats
| Sensitivity (%)* | Specificity (%)* | Confirmed (%)† | |||
|---|---|---|---|---|---|
| Rat | Sample-wise | Patient-wise | Sample-wise | Sample-wise | Patient-wise |
| 1 | 89 | 90 | 91 | 28 | 24 |
| 2 | 86 | 87 | 95 | 46 | 41 |
| 3 | 85 | 85 | 93 | 41 | 34 |
| 4 | 85 | 86 | 93 | 43 | 36 |
| 5 | 82 | 85 | 94 | 38 | 34 |
| 6 | 88 | 90 | 92 | 30 | 26 |
| 7 | 87 | 80 | 92 | 35 | 30 |
| 8 | 85 | 86 | 92 | 34 | 31 |
| 9 | 85 | 89 | 93 | 47 | 45 |
| 10 | 85 | 86 | 92 | 35 | 31 |
*
Relative to the results of Direct Observation Treatment Short-Course (DOTS) center microscopists viewing each side on one occasion.
†
DOTS-negative, rat-positive samples, and patients confirmed by Anti-Persoonsmijnen Ontmijnende Product Ontwikkeling (APOPO) microscopists as tuberculosis (TB)-positive.